Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Breast Cancer News ••• Topics • Countries • U.S. States

Breast Cancer Her2 News Monitoring

Get by Email • RSS

Published on 02:57 GMT

Early camizestrant therapy keeps advanced breast cancer in check

New research shows that early switching to camizestrant based on ctDNA detection of ESR1 mutations can keep breast cancer at bay longer, delivering hope for patients facing resistance to standard treatments. Study: First-Line Camizestrant for …

Source: Medical News - Neutral
Published on Jun 3, 2025

Kisqali Benefit Lasts Across Age in Breast Cancer Subset

Among patients with stage 2/3 hormone receptor–positive, HER2-negative early breast cancer, Kisqali (ribociclib) plus nonsteroidal aromatase inhibitor (NSAI) showed consistent benefits in invasive disease-free survival (iDFS), distant disease-free …

Source: Cure Today - Neutral
Published on Jun 3, 2025

Switching to Camizestrant After Detection of ESR1 Mutation Improves Progression-Free Survival for Some Breast Cancer ...

Results from the Phase III SERENA-6 clinical trial found that switching to treatment with camizestrant if an ESR1 mutation is detected during first-line treatment can help slow cancer growth for people with hormone receptor-positive, HER2-negative advanced …

Source: Cancer Health - Pending
Published on Jun 3, 2025

Novartis announces phase III NATALEE trial of Kisqali reduces risk of recurrence in younger patients with early breast ...

Novartis announces data from a new subgroup analysis of the phase III NATALEE trial evaluating the efficacy and safety of Kisqali (ribociclib) plus endocrine therapy (ET, a non-steroidal aromatase inhibitor) in patients with stage II and III hormone …

Source: Pharmabiz.com - Neutral
Published on Jun 3, 2025

AstraZeneca & Daiichi Sankyo announce positive results from DESTINY-Breast09 phase III trial of Enhertu plus pertuzumab ...

Positive results from the DESTINY-Breast09 phase III trial showed Enhertu (trastuzumab deruxtecan) plus pertuzumab demonstrated a highly statistically significant and clinically meaningful improvement in progression-free survival (PFS) compared to a taxane …

Source: Pharmabiz.com - Neutral
Published on Jun 3, 2025

ASCO 25: Enhertu bids for earlier use in HER2+ breast cancer

AstraZeneca and Daiichi Sankyo have revealed the data they hope will move Enhertu into frontline therapy for HER2-positive advanced breast cancer, including a 44% improvement in progression-free survival (PFS) compared to standard treatment. The DESTINY- …

Source: pharmaphorum - Neutral
Published on Jun 3, 2025

Dr Sammons on the Efficacy of RLY-2608 Plus Fulvestrant in PIK3CA-Mutant HR+/HER2– Breast Cancer

"We think that the combination of RLY-2608 and fulvestrant is very promising at this juncture in the post–CDK4/6 [inhibitor] setting, and we are excited to move it into a pivotal phase 3 trial." Sarah Sammons, MD, assistant professor of …

Source: OncLive - Pending
Published on Jun 3, 2025

Arvinas & Pfizer announces positive results from phase 3 VERITAC-2 trial of vepdegestrant to treat patients with ESR1-...

Arvinas, Inc., a clinical-stage biotechnology company, and Pfizer Inc. announced detailed results from the phase 3 VERITAC-2 clinical trial (NCT05654623) evaluating vepdegestrant monotherapy versus fulvestrant in adults with estrogen receptor-positive, …

Source: Pharmabiz.com - Neutral
Published on Jun 3, 2025

THP regimen achieves high response rates in HER2 positive breast cancer patients

Patients with Stage II and III (early-stage) HER2+ breast cancer usually undergo pre-operative therapy with multi-agent chemotherapy in combination with anti-HER2 antibodies, followed by surgery. A less intensive, reduced chemotherapy treatment approach is …

Source: Medical News - Neutral
Published on Jun 3, 2025

2025 ASCO Presentation: Innovent Biologics Announces Updated Data of IBI354 (Novel anti-HER2 ADC) From the Phase 1/2 ...

SAN FRANCISCO and SUZHOU, China, June 3, 2025 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of …

Source: The Laotian Times - Indeterminate
Published on Jun 3, 2025

Imlunestrant Alone or With Verzenios Improved PROs in Advanced Breast Cancer

Imlunestrant alone or in combination with Verzenios (abemaciclib) improved patient-reported outcomes among those with with estrogen receptor (ER)–positive, HER2-negative advanced breast cancer who progressed after endocrine therapy. Notably, these data …

Source: Cure Today - Neutral
Published on Jun 3, 2025

Understanding the Side Effects of RLY-2608 in HR+, HER2– Breast Cancer

Investigators evaluated the updated efficacy of treatment with RLY-2608, a mutant-selective PI3Kα inhibitor, when combined with Faslodex (fulvestrant) for patients with PIK3CA-mutant hormone receptor (HR)-positive, HER2-negative advanced breast cancer …

Source: Cure Today - Neutral
Published on Jun 3, 2025

Breast Cancer Targeted Therapies and Guidelines, Part 2

Photo Credit: iStock.com/Anastasia Usenko This slideshow highlights some of the latest breakthroughs in breast cancer treatment, spotlighting key molecular pathways—PI3K/AKT/mTOR, RAS/RAF/MEK/ERK, JAK/STAT, and SRC—that are …

Source: Physician's Weekly - Neutral
Published on Jun 3, 2025

Higher Pretreatment HER2 Amplicon mRNA Signature Predicts Improved Outcomes With Trastuzumab Deruxtecan in Metastatic ...

Patients with metastatic breast cancer who had higher pre-treatment HER2 amplicon mRNA (HER2DX) signatures and HER2 proteins (RPPA) who were treated with fam-trastuzumab deruxtecan-nxki (T-DXd; Enhertu) experienced a longer median time to next treatment ( …

Source: OncLive - Pending
Published on Jun 3, 2025

Dr Hamilton on Vepdegestrant vs Fulvestrant in ER+/HER2-Negative Advanced Breast Cancer

"VERITAC-2 met its primary end point. Vepdegestrant significantly improved progression free survival [at] 5.0 months compared [with] 2.1 months with fulvestrant among patients with ESR1 mutations." Erika Hamilton, MD, director of the Breast …

Source: OncLive - Pending
Published on Jun 3, 2025

Dr Tolaney on the PFS Benefit With First-Line T-DXd Plus Pertuzumab in HER2+ Breast Cancer

"In essence, T-DXd and pertuzumab almost doubled the duration of progression-free survival when compared with THP, and these benefits were seen across all the subgroups that were looked at." Sara M. Tolaney, MD, MPH, chief of the Division of …

Source: OncLive - Pending
Published on Jun 2, 2025

Pre-operative THP Achieves Pathological Complete Response in Two-Thirds of Early-Stage HER2-Positive, ER-Negative Breast ...

In recent advancements within the realm of breast cancer therapy, the CompassHER2 pCR trial emerges as a beacon of hope by investigating a less intensive neoadjuvant chemotherapy regimen for early-stage HER2-positive breast cancer patients. This …

Source: Bioengineer.org - Pending
Published on Jun 2, 2025

STAT+: Enhertu, used as first option, stalled tumors for more than a year in women with breast cancer, study finds

CHICAGO — The cancer drug Enhertu stalled the growth of tumors by well over a year in a group of women with a type of metastatic but previously untreated breast cancer — study results reported Monday that the drug’s makers AstraZeneca and Daiichi Sankyo …

Source: STAT - Massachusetts - Neutral
Published on Jun 2, 2025

Trastuzumab Deruxtecan Plus Pertuzumab Improves PFS vs Standard Care in HER2+ Breast Cancer

Trastuzumab deruxtecan (Enhertu; AstraZeneca/Daiichi Sankyo) in combination with pertuzumab (Perjeta; Genentech) demonstrated significantly longer progression-free survival (PFS) compared with the current standard of care for patients with locally …

Source: The American Journal of Managed Care - Neutral

28 days 06:02:56

Featured Releases

Got News to Share? · Submit · See All

Published on June 3, 2025 - 21:18 GMT

The Boob Bus Partners With Cigna Healthcare to Expand Access to Breast Cancer Screenings Across Utah

Serving More Than 1900 Utah Women Since Its Launch, The Boob Bus Continues To Expand Access To Breast Cancer Screening With New Insurance Contract SALT LAKE CITY, UT, UNITED STATES, June 3, 2025 /⁨EINPresswire.com⁩/ -- In another step towards …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 20:05 GMT

Cardiff Oncology Announces Positive Data from Investigator-Initiated Trial of Onvansertib in Combination with Paclitaxel ...

– Results from Phase 1b clinical trial evaluating onvansertib + paclitaxel for metastatic triple negative breast cancer demonstrated 40% objective response rate – – The trial evaluated three doses of onvansertib in combination with paclitaxel, and …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on June 3, 2025 - 13:36 GMT

New Collaboration Between Psifas and OpenDNA: Predicting Common Diseases Through AI and Genomic Data

HAIFA, ISRAEL, ISRAEL, June 3, 2025 /⁨EINPresswire.com⁩/ -- The Israeli National Initiative for Personalized Medicine, Psifas, and OpenDNA a Genomic AI biotech company have announced a strategic collaboration to develop artificial intelligence …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 3, 2025 - 15:22 GMT

Acne Awareness Month: Expert Tips from Naples Soap Company for a Clear, Healthy Summer Skin

NAPLES, FL, UNITED STATES, June 3, 2025 /⁨EINPresswire.com⁩/ -- June marks Acne Awareness Month, highlighting an important season for skin health. As outdoor temperatures rise and humidity increases, many individuals experience an uptick in …

Distribution channels: Beauty & Hair Care, Business & Economy ...

Published on June 2, 2025 - 14:30 GMT

4D Path Presents Breakthrough Research Demonstrating That Its Unique Digital Predictive Biomarker Identifies Treatment ...

NEWTON, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- 4D Path, a company dedicated to personalizing cancer care through its unprecedented approach to predicting tumor response, unveiled groundbreaking findings at the American Society of Clinical Oncology (ASCO …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 3, 2025 - 11:30 GMT

Breast Reconstruction Surgery Market Set for Strong Growth, Hitting USD 10.1 Billion by 2035

Surgical Reconstruction to Dominate Breast Surgery Market with 77.2% Share in 2025 NEW YORK, DE, UNITED STATES, June 3, 2025 /⁨EINPresswire.com⁩/ -- The global breast reconstruction surgery market is forecast to grow from USD 4.9 billion in 2025 to USD 10 …

Distribution channels: Technology ...
Published on June 3, 2025 - 20:30 GMT

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN FRANCISCO, June 03, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on May 31, 2025 - 12:00 GMT

Arvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/...

Pivotal Phase 3 VERITAC-2 clinical trial results presented at ASCO demonstrate 2.9-month improvement in median progression-free survival when compared to fulvestrant in second line-plus patients with an estrogen receptor 1 mutation Vepdegestrant was …

Distribution channels: Companies, Culture, Society & Lifestyle ...

Got news to share? Submit it now.

Load more breast cancer news or search news using your own keywords. There are 818,842,806 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Breast Cancer News by Country

Breast Cancer News by U.S. State

Breast Cancer News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 05/18/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on June 4, 2025 - 02:30 GMT

Dental X-ray Systems Market to Hit USD 3.5 Billion by 2035, Growing at 5.2% CAGR

Global Dental X-ray Systems Market Set to Double by 2035 with Rising Oral Health Awareness NEW YORK, DE, UNITED STATES, June 4, 2025 /⁨EINPresswire.com⁩/ -- The global dental X-ray systems market is projected to grow from USD 1.5 billion in 2025 …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 4, 2025 - 00:00 GMT

Dino Miliotis Reframes the AI Conversation in Modern Healthcare

Tech Frontman and Recovery Advocate Calls for Clarity, Ethics, and Smarter Tools—Not Human Replacement. CHICAGO, IL, UNITED STATES, June 3, 2025 /⁨EINPresswire.com⁩/ -- As public anxiety over artificial intelligence grows, recovery advocate and …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on June 4, 2025 - 00:00 GMT

Consilium Releases 2025 Trends in Locum Tenens Report, Revealing Data-Driven Insights for Healthcare Success

Consilium shares insights that demonstrate their ongoing commitment to excellence in healthcare staffing success. IRVING, TX, UNITED STATES, June 3, 2025 /⁨EINPresswire.com⁩/ -- Consilium today announced the release of its comprehensive 2025 …

Distribution channels: Emergency Services, Healthcare & Pharmaceuticals Industry ...
Published on June 3, 2025 - 23:41 GMT

Fight Health Insurance Makes AI Billing Assistant Doughnut Free for Patients and Providers

Fight Health Insurance launches free AI billing chat for patients and providers, and adds customizable prior authorization letters for healthcare professionals SAN FRANCISCO, CA, UNITED STATES, June 3, 2025 /⁨EINPresswire.com⁩/ -- Conversational …

Distribution channels: Banking, Finance & Investment Industry, Companies ...
Published on June 3, 2025 - 22:00 GMT

Antioch University Approved to Launch Graduate Nursing Programs Nationwide

Programs to Be Delivered Online, Expanding Access for Working Professionals YELLOW SPRINGS, OH, UNITED STATES, June 3, 2025 /⁨EINPresswire.com⁩/ -- Antioch University is proud to announce that the Higher Learning Commission’s Institutional …

Distribution channels: Business & Economy, Education ...
Published on June 3, 2025 - 21:18 GMT

The Boob Bus Partners With Cigna Healthcare to Expand Access to Breast Cancer Screenings Across Utah

Serving More Than 1900 Utah Women Since Its Launch, The Boob Bus Continues To Expand Access To Breast Cancer Screening With New Insurance Contract SALT LAKE CITY, UT, UNITED STATES, June 3, 2025 /⁨EINPresswire.com⁩/ -- In another step towards …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on June 3, 2025 - 20:59 GMT

Melbourne Pharma Brings Expert Dermatological Compounding to Florida’s Sunshine State

Melbourne Pharma offers expert, custom dermatology compounding for Florida patients—led by pharmacist Mike Boehmer. MELBOURNE, FL, UNITED STATES, June 3, 2025 /⁨EINPresswire.com⁩/ -- With Florida’s abundant sunshine comes an increased need for …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on June 3, 2025 - 19:55 GMT

Momentive Appoints Craig Borkowski as New Chief Executive Officer

NISKAYUNA, NY, UNITED STATES, June 3, 2025 /⁨EINPresswire.com⁩/ -- Momentive Performance Materials (Momentive), a global high-performance silicones and specialty solutions company, is pleased to announce the appointment of Craig Borkowski as Chief …

Distribution channels: Agriculture, Farming & Forestry Industry, Chemical Industry ...
Published on June 3, 2025 - 19:46 GMT

Testosterone Replacement Therapy Shows Mixed Effects on Heart Disease Risk, According to New Research Studies

Men with hypogonadal symptoms (low libido, muscle loss, erectile dysfunction, fatigue, etc.) show benefits from properly dosed and monitored TRT services NEW ORLEANS, LA, UNITED STATES, June 3, 2025 /⁨EINPresswire.com⁩/ -- Testosterone Replacement …

Distribution channels: Business & Economy, Culture, Society & Lifestyle ...
Published on June 3, 2025 - 19:04 GMT

Longevity Leadership Conference Returns to Los Angeles: A Premier Gathering of Industry Innovators and Investors

Explore the intersection of science, medicine, investment, and business at the forefront of the longevity revolution. LOS ANGELES, CA, UNITED STATES, June 3, 2025 /⁨EINPresswire.com⁩/ -- Healthspan Productions, in partnership with Mission Matters …

Distribution channels: Business & Economy, Conferences & Trade Fairs ...
Published on June 3, 2025 - 18:56 GMT

Formaspace Announces Strategic Lab Chair Partnership with Cramer

Formaspace features specialized Cramer chairs—Fusion, Helix, and Loop—at NeoCon 2025, showroom #11-124. Built for labs, cleanrooms, and technical spaces. AUSTIN, TX, UNITED STATES, June 3, 2025 /⁨EINPresswire.com⁩/ -- Formaspace is announcing a …

Distribution channels: Companies, Conferences & Trade Fairs ...
Published on June 3, 2025 - 18:56 GMT

Westfield Washington Schools & Bosma Enterprises Partner to Advance Student Vision Screenings with Good-Lite Technology

Westfield Schools partner with Bosma to enhance student vision screenings using Good-Lite’s LED Insta-Line Cabinet for accurate, efficient testing. WESTFIELD, IN, UNITED STATES, June 3, 2025 /⁨EINPresswire.com⁩/ -- Westfield Washington Schools ( …

Distribution channels: Business & Economy, Companies ...
Published on June 3, 2025 - 18:55 GMT

Good-Lite Company. Now a preferred supplier for U.S. Veterans Association through GSA Schedule

Good-Lite Company is proud to announce its inclusion on the United States Veterans Association's list of preferred suppliers. ELGIN, IL, UNITED STATES, June 3, 2025 /⁨EINPresswire.com⁩/ -- Good-Lite Company., a leader in visual acuity …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on June 3, 2025 - 17:52 GMT

Retinitis Pigmentosa Therapeutics Enter New Era as Gene-Agnostic & Intravitreal Therapies Redefine Competitive Landscape

Retinitis Pigmentosa therapies evolve beyond gene-specific fixes with gene-agnostic, intravitreal, and optogenetic advances reshaping the treatment landscape. AUSTIN, TX, UNITED STATES, June 3, 2025 /⁨EINPresswire.com⁩/ -- The treatment paradigm …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 3, 2025 - 17:22 GMT

Next-Generation Therapies Reshape Gaucher’s Disease as Gene Therapy Advances Challenge Enzyme Replacement Dominance

Gene therapies challenge ERT dominance in Gaucher’s disease as new data reveals strategic insights, key players, and future treatment opportunities. AUSTIN, TX, UNITED STATES, June 3, 2025 /⁨EINPresswire.com⁩/ -- The Gaucher’s disease (GD) …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 3, 2025 - 17:20 GMT

Blue Goat Cyber Sponsors LSI Asia 2025; CTO Trevor Slattery to Lead High-Impact MedTech Cybersecurity Panel

Blue Goat Cyber sponsors LSI Asia 2025 and leads a MedTech cybersecurity panel on avoiding regulatory and market pitfalls in APAC. SCOTTSDALE, AZ, UNITED STATES, June 3, 2025 /⁨EINPresswire.com⁩/ -- Blue Goat Cyber, a trusted authority in medical …

Distribution channels: Companies, Conferences & Trade Fairs ...
Published on June 3, 2025 - 16:58 GMT

Global Hemp Fiber Market Set For 36.4% Growth, Reaching $71.96 Billion By 2029

The Business Research Company’s Hemp Fiber Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 3, 2025 /⁨EINPresswire.com⁩/ -- The hemp fiber market has seen unprecedented growth in …

Distribution channels: Business & Economy, Food & Beverage Industry ...
Published on June 3, 2025 - 16:56 GMT

Industrial Dispensing System And Equipment Market Forecast 2025-2034: Comprehensive Insights On Market Size, Growth

The Business Research Company’s Industrial Dispensing System And Equipment Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 3, 2025 /⁨EINPresswire.com⁩/ -- The industrial …

Distribution channels: Automotive Industry, Business & Economy ...
Published on June 3, 2025 - 16:52 GMT

Figure Skater’s Legacy Becomes Maine Haven: Tessa’s House Opens 16 Beds for Women in Recovery

Trauma-informed, women-only facility honoring Tessa Lee McCue’s legacy and funded by a $1.1 million Maine Recovery Council grant. WASHINGTON, ME, UNITED STATES, June 3, 2025 /⁨EINPresswire.com⁩/ -- Addiction remains one of the most urgent women's …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 3, 2025 - 16:50 GMT

Blue Goat Cyber Sponsors DeviceTalks Minnesota; Jordan John to Share FDA Cybersecurity Strategies

Blue Goat Cyber joins DeviceTalks Minnesota to showcase expert strategies for FDA-ready medical device cybersecurity and regulatory compliance. SCOTTSDALE, AZ, UNITED STATES, June 3, 2025 /⁨EINPresswire.com⁩/ -- Blue Goat Cyber, a leading …

Distribution channels: Companies, Conferences & Trade Fairs ...